Article
Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.
Lung cancer (Amsterdam, Netherlands) - 1 Mar 2013
Choi Hongyoon, Paeng Jin Chul, Kim Dong-Wan, Lee June Koo, Park Chang Min, Kang Keon Wook, Chung June-Key, Lee Dong Soo
Abstract excerpt
INTRODUCTION: ALK rearrangement in lung cancer has been identified as a novel molecular target in lung adenocarcinoma. In this study, we evaluated metabolic and metastatic features of lung adenocarcinoma by using FDG PET/CT, with regard to specific genotypes of ALK and EGFR mutation. METHODS: Patients with lung adenocarcinoma initially diagnosed and examined with FDG PET/CT and molecular genotyping with biopsy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
